5 "Strong Buy" Stocks Under $10 to Own for 2021

NYSE: UMC | United Microelectronics Corp. ADR News, Ratings, and Charts

UMC – United Micro Corporation (UMC), Wipro Limited (WIT), CimbaBay Therapeutics (CBAY), Pacific Ethanol (PEIX) and Surface Oncology (SURF) are five stocks, under $10, that are rated “Strong Buys” and should continue to see gains in 2021.

Plenty of tech stocks and other growth-oriented stocks are clearly overpriced at this point. However, there are some unrecognized diamonds in the rough, many of which are priced under $10.

Stocks priced under $10 are particularly attractive as they generate significant interest from everyday traders looking to buy into companies with lower share prices. 

Below, using the POWR Ratings service, we provide a look at five “Strong Buy” stocks priced under $10: United Micro Corporation (UMC), Wipro Limited (WIT), CimbaBay Therapeutics (CBAY), Pacific Ethanol (PEIX) and Surface Oncology (SURF).

United Microelectronics Corporation (UMC - Get Rating)

Semiconductor applications require foundry services provided by the likes of UMC. In particular, UMC’s primary strength is in generating integrated circuit wafers customized for each individual client.

Take a look at UMC’s POWR Ratings and you will find it has “A” grades in Trade Grade, Peer Grade, and Industry Rank, and a “B” Buy & Hold grade. The stock is ranked in the top 10 of 86 in the Semiconductor & Wireless Chip category.

Out of six analysts who cover the stock, five rate it as a Buy, and one rates it as a Hold. In September, UMC’s revenue spiked by more than 30%, which was the company’s best monthly growth since spring. The company will continue its production expansion capacity through next year, providing wafers and other process technologies for its ever-growing client base.

Wipro Limited (WIT - Get Rating)

This global IT services provider specializes in consulting, software solutions, BPO services and more. WIT has clients across the globe. The WIT POWR Ratings reveal “A’s” for Trade Grade and Buy & Hold Grade, and “B’s” for the Peer Grade and Industry Rank components.. WIT is ranked third of 14 stocks in the Outsourcing – Tech Services category.

WIT’s forward P/E ratio of 23 is fairly reasonable considering its sector is filled with companies with much higher forward P/Es. WIT quickly climbed from $4.35 on 9/20 to more than $5.

CimbaBay Therapeutics (CBAY - Get Rating)

If you are looking for an opportunity to invest in a biopharmaceutical company that develops and commercializes proprietary new medicine to treat diseases, CBAY is worthy of your consideration. As an example, CBAY’s arhalofenate appears to successfully treat gout.

CBAY receives “A’s” for Trade Grade, Buy & Hold Grade, and Peer Grade. The stock is ranked in the top 40 out of nearly 400 in the Biotech sector. The top analysts are uber-bullish on CBAY, setting an average price target of $13.25, meaning there is more than 70% potential upside.

CBAY has even more momentum now that it is resuming development of its lead drug candidate that treats diabetes and other health maladies. 

Pacific Ethanol (PEIX - Get Rating)

Ethanol marketing and production is now big business. PEIX markets this fuel throughout the western portion of the United States. Furthermore, PEIX is now producing ethanol at its site in Madera County, CA.

In the POWR Ratings, PEIX receives “A’s” in Trade Grade, Buy & Hold Grade, Peer Grade, and a “B” for Industry Rank.  The stock is ranked in the top 10 of 28 in the Agriculture space. The top analysts insist PEIX is under-priced, setting an average price target of $16.50, meaning it has more than 73% potential upside.

Shares of this up-and-coming stock soared in September as its ethanol is used in disinfectants and sanitizers the masses are relying on to combat the spread of COVID-19. If a second wave of the virus emerges, PEIX should move even higher.

Surface Oncology (SURF - Get Rating)

SURF develops therapies for cancer treatment. SURF’s product pipeline is currently in the clinical stage, meaning it has unrealized potential.

SURF has “A” grades in three of the four POWR Rating components. The stock is ranked in the top 30 of 239 publicly traded companies in the Medical – Pharmaceuticals space.

SURF recently popped when news broke of the company hiring an investment bank to look into the company’s sale. If an industry power player such as GlaxoSmithKline makes a move to scoop up SURF, the stock will undoubtedly go even higher.

Want More Great Investing Ideas?

2020 Stock Market Bubble Part 2?

7 Best ETFs for the NEXT Bull Market

5 WINNING Stocks Chart Patterns


UMC shares were trading at $5.50 per share on Wednesday afternoon, up $0.05 (+0.92%). Year-to-date, UMC has gained 112.70%, versus a 9.66% rise in the benchmark S&P 500 index during the same period.


About the Author: Patrick Ryan


Patrick Ryan has more than a dozen years of investing experience with a focus on information technology, consumer and entertainment sectors. In addition to working for StockNews, Patrick has also written for Wealth Authority and Fallon Wealth Management. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
UMCGet RatingGet RatingGet Rating
WITGet RatingGet RatingGet Rating
CBAYGet RatingGet RatingGet Rating
PEIXGet RatingGet RatingGet Rating
SURFGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Why is Stock Market Outlook So Uncertain?

The S&P 500 (SPY) has quickly pushed back from the highs and once again on the verge of a break below the 100 day moving average. Why is this happening? And what comes next? 40 year investment veteran Steve Reitmeister shares his view and top stocks in the commentary that follows...

3 Under-the-Radar Tech Stocks Quietly Powering the Digital Revolution

The technology industry's future seems promising, owing to increasing investments and rising worldwide demand for better products. Hence, investing in fundamentally stable tech stocks, Motorola (MSI), Power Integrations (POWI), and CI&T (CINT) could be the move for investors looking to capitalize on the sector's growth. Read on…

3 AI-Powered Drug Discovery Stocks Revolutionizing Medicine

The pharmaceutical industry is evolving continuously with the advancements in drug discovery with Artificial Intelligence (AI), propelling the industry’s growth. Amid this backdrop, quality medical stocks Pfizer (PFE), AstraZeneca (AZN), and Novartis (NVS), which are transforming medicine with AI-powered drug discovery, could be ideal portfolio additions. Continue reading...

3 Metaverse Stocks Building the Virtual Economy

The metaverse isn’t just a futuristic fantasy; it’s shaping up to be the next big digital economy. As digital spaces evolve into thriving marketplaces, companies like Apple (AAPL), NVIDIA Corp. (NVDA), and Meta Platforms (META) are building the foundation for this new era. Thus, investing in them could be rewarding. Read more…

Trump or the Fed More Important to Stock Investors?

The S&P 500 (SPY) is flirting with new highs once again. But it is not very clear what is driving these stock price gains. That is why Steve Reitmeister shares his latest views including a market outlook, trading plan and top picks to stay on the right side of the action.

Read More Stories

More United Microelectronics Corp. ADR (UMC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All UMC News